Remove .Net Remove Development Remove Licensing Remove Pharmaceuticals
article thumbnail

Seattle-based Icosavax, which is developing COVID-19 vaccines, files for IPO 4 years after launch

GeekWire

Icosavax creates virus-like particles with technology licensed from the University of Washington’s Institute for Protein Design. The company, a spin-out from the UW’s Institute for Protein Design , is developing vaccines to resemble naturally occurring viruses. Net losses were $5.3 Icosavax Photo).

article thumbnail

Tech Moves: Top Blue Origin engineer joins SpaceX; Axon hires HTC Vive exec; Porch adds to board

GeekWire

Prior to joining Convoy in 2018, Kreiner was CEO of Cal Net Technology Group and a managing partner at Olympic Valley Capital. New Athira execs Mark Worthington, general counsel, and Rachel Lenington, chief technology officer and head of product development strategy. Athira Photos). Read the story. Lessen Photo). Scottsdale, Ariz.-based

CTO Hire 133
article thumbnail

Rep. Pramila Jayapal on vaccine equity, misinformation, preparing for the next pandemic

GeekWire

Other countries like Germany put in place automatic stabilizers so that when an emergency happens, whether it’s a health emergency or an economic emergency, the government automatically kicked in levels of funding and social safety net support services and health services and other things that people would need. “The U.S.